Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer

NCT02424617

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Horizon Oncology Research, Lafayette, Indiana, United States
View Trial Details
Completed

Afatinib in NSCLC With HER2 Mutation

NCT02597946

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Hunan Province Tumor Hospital Changsha, China
  • First Affiliated Hospital of Guangzhou Medical University Guangzhou, China
  • Zhejiang Cancer Hospital Hangzhou, China
  • The Second Affiliated Hospital to Nanchang University Nanchang, China
View Trial Details
Completed

Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)

NCT03669523

Conditions
Bone Metastases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • CH du Pays d'Aix Aix-en-Provence, France
  • Chu Angers Angers, France
  • Centre Hospitalier de Beauvais Beauvais, France
  • Centre Hospitalier Fleyriat Bourg-en-Bresse, France
View all 27 locations
View Trial Details
Completed

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

NCT01346540

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1199.82.39004 Boehringer Ingelheim Investigational Site Milan, Italy
  • 1199.82.3102 Boehringer Ingelheim Investigational Site Maastricht, Netherlands
  • 1199.82.3401 Boehringer Ingelheim Investigational Site Barcelona, Spain
  • 1199.82.3406 Boehringer Ingelheim Investigational Site Madrid, Spain
View Trial Details

Related conditions